Comparison of an innovative multi-dose inhaler with the attributes of an 'ideal' inhaler: A multicentre randomised controlled trial (RCT)

S. Jones, R. Clarke, S. Eason, P. Swanbury, A. Scrimgeour, N. Ellis (Holzkirchen, Germany; Cambridge, Chippenham, United Kingdom)

Source: International Congress 2014 – Rationale behind respiratory drug development
Session: Rationale behind respiratory drug development
Session type: Thematic Poster Session
Number: 937
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Jones, R. Clarke, S. Eason, P. Swanbury, A. Scrimgeour, N. Ellis (Holzkirchen, Germany; Cambridge, Chippenham, United Kingdom). Comparison of an innovative multi-dose inhaler with the attributes of an 'ideal' inhaler: A multicentre randomised controlled trial (RCT). Eur Respir J 2014; 44: Suppl. 58, 937

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Abediterol in stable asthma:efficacy, safety and tolerability results from a Phase II, randomised, crossover study
Source: International Congress 2014 – Asthma and COPD management
Year: 2014

Assessment of the bioequivalence of two DPIs containing fluticasone and salmeterol, in patients with controlled or partly controlled asthma
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016


Roflumilast for stable COPD: Meta-analysis of randomized controlled trials
Source: International Congress 2014 – Clinical presentations
Year: 2014


Efficacy and safety of abediterol (LAS100977) in stable asthma: Phase II, randomized, crossover study
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

Efficacy of the Plasma Cluster® device in mild to moderate asthmatic children: A randomized, double-blind, placebo-controlled, proof-of-concept trial
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013

Effectiveness of a pharmacist-led inhalation technique intervention on asthma and COPD patients: The INspira cluster-randomized controlled trial
Source: Virtual Congress 2021 – Highlights for primary care in 2021
Year: 2021



INSTEAD: Randomized switch trial of indacaterol and salmeterol/fluticasone combination (SFC) in moderate COPD: Symptoms results
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015

Randomized, controlled study of the impact of a mobile health tool on asthma SABA use, control and adherence
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016

Efficacy and safety of abediterol (LAS100977) in patients with COPD: Phase II, randomised, crossover study
Source: Annual Congress 2013 –New bronchodilators for COPD management
Year: 2013

Pharmacological effect of lysozyme for COPD and bronchial asthma with sputum: A randomized, placebo-controlled, cross-over study
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014


Reframing asthma and inhaled corticosteroids (ICS) to modify treatment beliefs: an online randomised controlled trial
Source: International Congress 2018 – Educational tools to improve your practice
Year: 2018



Effectiveness of an intervention of Urban Training in patients with COPD: a randomized controlled trial
Source: International Congress 2017 – The importance of physical activity in patients with COPD
Year: 2017


Pharmacokinetic interaction of glycopyrronium bromide pMDI and formoterol pMDI: A randomized, open-label, single-dose, 4-way cross-over study
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015


Efficiency of physiotherapy with Caycedian Sophrology on children with asthma: a randomized controlled trial.
Source: International Congress 2018 – Paediatric asthma: new insights in its prevalence, treatment and treatment failure
Year: 2018

Safety profile of glycopyrronium in patients with COPD: An innovative approach to analyse data from post-marketing surveillance (PMS)
Source: International Congress 2014 – Asthma and COPD management
Year: 2014


Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial
Source: Eur Respir J 2001; 18: Suppl. 33, 518s
Year: 2001

An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014


“Stepping down” in mild-to-moderate asthmatic children being well controlled while receiving low doses of inhaled corticosteroids (ICS): Daily vs. cyclical ICS administration (prospective, randomized, multicentre, open-label trial)
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013


A randomized phase 3 study of the efficacy and safety of reslizumab in subjects with asthma with elevated eosinophils
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014

Effectiveness and acceptability of a smart inhaler asthma self-management programme: a cluster RCT study protocol
Source: International Congress 2019 – Innovations in primary care assessment and management
Year: 2019